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Estrogen enhances stress-induced prefrontal
cortex dysfunction: relevance to Major
Depressive Disorder in women
The medial prefrontal cortex (PFC) is widely recognized
as a site of dysfunction in patients with stress-related dis-
orders,
8 particularly MDD.Post-mortem studies of sui-
cide victims’ brains reveal marked morphological
changes—most notably,reduced glia and neuron number
in the ventromedial PFC.
9 Similarly,magnetic resonance
imaging (MRI) studies demonstrate reduced volume of
this area in depressed patients,
10 as well as abnormal
activity.
11The PFC integrates information from multiple
brain areas to regulate behavior,thought,and affect
12—
functions that are often compromised in MDD patients.
13
In animal models,the integrity of the PFC is most com-
monly tested using working memory tasks,which require
animals to keep information “online”in the absence of
external cues,continually update information,and inhibit
inappropriate responses.Exposure to stress has consis-
tently been shown to impair performance on such tasks
in nonhuman primates and male rodents,
14 but until
recently,neither sex differences nor estrogen effects on
this phenomenon had been explored.
The first studies to examine sex differences in the effects
of stress on PFC function elicited the stress response in
young adult male and female rats with injections of vary-
ing doses of the benzodiazepine inverse agonist FG7142.
FG7142 is a well-documented anxiogenic drug that is fre-
quently used as a model for stress,given its reliability in
producing the biochemical and physiological effects of
stress:increased corticosterone release,increased cate-
cholamine turnover,elevated heart rate,and increased
blood pressure.
15 Moreover, animals that have been
administered FG7142 exhibit classic stress-related behav-
iors,including defecating,urinating,freezing,and ultra-
sonic vocalizations.
16
Following FG7142 administration,animals were tested
on a classic measure of working memory—delayed alter-
nation in the T-maze.At high doses of FG7142,all ani-
mals displayed impairment on the T-maze. At lower
doses,however,only females showed impairment,sug-
gesting that they were more sensitive to the detrimental
effects of stress on mPFC function (Figure 1a).To test
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It is well documented that exposure to stress can precipitate or exacerbate many mental illness-
es,
1,2 including major depressive disorder (MDD) and post-traumatic stress disorder (PTSD).
Women are twice as likely as men to develop these disorders,
3,4 as well as most anxiety disorders
and phobias,
5 but the biological causes of this discrepancy are poorly understood. Interestingly,
there is evidence that the increased prevalence of MDD in women occurs primarily during the
childbearing years, when circulating estrogen is present.
6,7 These observations raise questions as
to whether men and women have distinct neurobiological responses to stress, and if so, how
might estrogen mediate these differences? Attempts to answer these questions in animal models
have generated a growing body of literature demonstrating that estrogen can, indeed, modulate
the effects of stress in the brain. Moreover, these effects are demonstrable in brain regions rele-
vant to MDD, and are consistent with the idea that estrogen might enhance the stress response,
promoting a greater vulnerability to mental illness.whether fluctuating hormones produced this sex effect,
the experiment was repeated while female rats’ estrus
phase was monitored.It was found that these rats only
displayed sensitivity to FG7142 during proestrus,when
estrogen levels are highest.Animals in estrus,character-
ized by low estrogen levels,responded to the low dose of
FG7142 in a manner comparable to that of males—that
is,showing no impairment at all
17 (Figure 1b).This effect
was further replicated using a more conventional stress
paradigm,restraint.While 2 hours of restraint stress pro-
duced working memory impairments in all groups,only
females in proestrus were impaired by 1 hour of restraint
as well (Figure 1c).
18Taken together,these studies suggest
that fluctuating hormones can interact with stress systems
to modulate PFC function during stress.
This idea was explored further by ovariectomizing a new
group of female rats,and implanting a time-release cap-
sule containing either estrogen (OVX + E) or cholesterol
(OVX) as a control.These rats were then treated with the
same low dose of FG7142 that impaired proestrus
females,but not estrus females or males,and then tested
on the T-maze task. Strikingly similar results were
found—like females in proestrus,the estrogen-treated
animals were impaired by this low dose,while OVX ani-
mals, like estrus females or males, were unaffected.
Collectively, this and the above studies provide com-
pelling evidence that high levels of estrogen, whether
occurring naturally or experimentally,can produce a sen-
sitivity to the detrimental effects of stress in the PFC
(Figure 1b).The possible mechanisms by which estrogen
confers this sensitivity have only just begun to be illumi-
nated.
The PFC receives sizeable afferents from midbrain cate-
cholaminergic nuclei locus coeruleus (LC),
19 the primary
source of norepinephrine (NE),and ventral tegmental
area (VTA),the primary source of dopamine (DA).The
influence of these projections on PFC functioning has
been extensively studied,and it is widely accepted that
the relationship between catecholamine levels in the PFC
and working memory performance is manifest in an
“inverted U”curve.
20 Specifically,experimental or age-
related catecholamine depletion produces PFC-mediated
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Figure 1. Sex differences and estrogen effects on stress-induced working
memory impairment. a) Dose-response curve for male and female
animals’ performance on working memory task delayed alterna-
tion after administration of pharmacological stressor FG7142.
Mean scores after 0, 0.5, 2, 5, 10, and 15 mg/kg respectively were,
for males, 76+/-2.7, 79+/-7.5, 76+/-4.6, 55+/-9, 50+/-7.5, and
48+/-4.2; for females, 69.7+/-3.4, 66+/-8.4, 51.67+/-10, 50+/-8,
50+/-6.1, and 37+/-8. Repeated measures ANOVA revealed a sig-
nificant sex x drug interaction F(5,40)=2.4, P=0.05). Post-hoc analy-
sis (test of effects) showed the 2 mg/kg dose to have the most
prominent sex difference, where the females were impaired, but
the males were not F(1,8)=6.2, P<.04. b) Working memory per-
formance after 2 mg/kg FG7142 varied according to estrogen lev-
els. Scores after vehicle or 2 mg/kg FG7142, respectively were, for
intact females in proestrus, 75+/-6 and 57.7+/-2.3; for intact
females in estrus, 74+/-6 and 81+/-4.5; for ovariectomized (OVX)
females, 79+/-6.5 and 73+/-6.7; for OVX females with estrogen
replacement (OVX + E), 79+/-5.5 and 65+/-4.5. In both experi-
ments, animals with high estrogen levels (proestrus and OVX + E)
were significantly impaired by FG7142 (P<.0002 and P<.03,
respectively). c) Working memory performance after restraint stress
varied according to estrogen levels. Scores after 0, 1, or 2 h
restraint stress, respectively were, for males: 73.3+/-2.3, 76+/-4.5,
and 58+/-7.42; females in estrus, 72.3+/-2.1, 75+/- 3.6, and
62.8+/-6.55; for females in proestrus, 69.3+/-2, 50+/-3.7, and
60+/-5.7. Only females in proestrus were significantly impaired by
1 h restraint (P<.0005). * = significantly different from self in con-
trol conditions, † = significantly different from self in estrus.
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21 that can be
reversed with administration of DA or NE receptor ago-
nists.
22,23 However, extreme  increases in mPFC cate-
cholamine levels can also have a detrimental effect on
PFC function (Figure 2),exerting their actions through
the very receptors that restore performance in animals
whose catecholamine systems have been compromised.
Such increases in catecholamine release are seen with
stress,
24 and it has been shown in male rats that stress-
induced PFC dysfunction is due in part to binding of the
DA D1 receptor,and the subsequent activation of the pro-
tein kinase A (PKA) intracellular signaling pathway.
25,26
Conversely,stress-induced impairments can be reversed
through stimulation of the NE α-2 receptor,
27 whose acti-
vation leads to an inhibition of PKA activity.
To examine whether estrogen’s enhancement of stress-
induced PFC dysfunction was due to actions at the NE
α-2 receptor, OVX and OVX + E animals were coad-
ministered an impairing dose of FG7142 and a dose of
the α-2 agonist guanfacine (GFC) known to restore
stress-related performance deficits in males, and then
tested on the delayed alternation task.Although OVX
animals required almost three times as much FG7142 as
OVX + E in order to show impairment, OVX showed
complete reversal of the impairment with GFC, while
OVX + E showed no improvement (Figure 3). These
results suggest that estrogen might cause sensitivity to
stress-induced PFC dysfunction through suppression of
an animal’s responsiveness to NE α-2 stimulation.
Western Blot analysis showed no difference in PFC NE
α-2 protein levels between OVX and OVX + E (Figure
4),indicating that this effect is not due to changes in pro-
tein expression,but likely to actions downstream of the
receptor.The exact mechanism by which estrogen elicits
this effect has yet to be identified. However, estrogen
treatment has been shown in hypothalamus to uncouple
the NE α-2 receptor from its G-protein,
28 thus rendering
it ineffective. If this likewise occurs in the PFC, GFC’s
inability to rescue working memory function in stressed
OVX + E animals could thus be explained.
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Figure 2. The correlation between accuracy of delayed alternation perfor-
mance in the rat and the ratio of DOPAC to dopamine in the pre-
frontal cortex. Rats were given vehicle or FG7142 (20 mg/kg)
before being tested on delayed alternation, and were sacrificed
immediately after testing. Increased dopamine turnover in the pre-
frontal cortex significantly correlated with impaired performance
on the delayed alternation task (r=0.627, P<0.01). DOPAC, 3,4-
dihydrophenylacetic acid; DA, dopamine
Reproduced from reference 24: Murphy BL, Arnsten AFT, Goldman-Rakic
PS, Roth RH. Increased dopamine turnover in the prefrontal cortex impairs
spatial working memory performance in rats and monkeys. Proc Natl Acad
Sci U S A. 1996;93:1325-1329. Copyright © National Academy of Sciences
1996.
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Figure 3. Estrogen suppresses norepinephrine (NE) -2 receptor-mediated
rescue of working memory function during stress. a) OVX and OVX
+ E were administered increasing doses of FG7142 in order to find
the lowest impairing dose for each animal. b) Despite receiving
higher doses of FG7142 (10+/-3.7 mg/kg vs 3.5+/-1.2 mg/kg), OVX
showed full rescue of PFC function with coadministration of NE α-
2 agonist guanfacine (GFC), while OVX + E showed no improve-
ment (scores of 74.3+/-3.9 vs 47.5+/-5.5, P<.0007). *, significantly
different from self in control conditions, †, significantly different
from OVX in same condition. PFC, prefrontal cortex
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abThe work described here demonstrates that female rats
are more sensitive to stress-induced PFC dysfunction,
especially under conditions of high estrogen levels.While
this heightened stress response may confer survival value
during danger, it may also increase susceptibility for
stress-related disorders such as depression.That estrogen
also mediated distinct responses to actions at NE α-2
receptors suggests that a more thorough investigation of
hormone-intracellular signaling cascade interactions may
yield useful information regarding the potential preven-
tion and treatment of stress-induced disorders in women.
A better understanding of the neurobiology underlying
sex differences in the cognitive response to stress is
imperative in forwarding the development of more
appropriate therapeutic targets and methods.❏
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Figure 4. Estrogen does not affect norepinephrine -2 receptor expression
in the PFC. As assessed by Western Blot, OVX and OVX + E did
not differ in their levels of NE α-2 protein. PFC, prefrontal cortex
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